Masimo Corporation (MASI)
Oxford Ledge is still expanding full research coverage of MASI. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Masimo develops and sells noninvasive patient monitoring technologies and hospital automation solutions to healthcare providers globally.
SEC filings
- 10-Q Quarterly financial report (unaudited) 2026-05-05
- 8-K Shareholder vote results; Regulation FD disclosure; Financial statements and exhibits 2026-05-04
- 10-K/A Amended annual report 2026-05-01
- 8-K Other material event 2026-04-23
- 10-K Annual financial report with audited statements 2026-02-27
Source: SEC EDGAR.
Annual results
5 years of annual figures for MASI, as filed with the SEC. Figures are as reported and are not restated or adjusted.
| Fiscal year | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| 2026 | $1.53B | -$151.5M | -$2.80 |
| 2024 | $1.40B | -$304.9M | -$5.60 |
| 2023 | $1.28B | $81.5M | $1.51 |
| 2022 | $1.24B | $143.5M | $2.60 |
| 2021 | $1.14B | $240.3M | $4.14 |
Source: SEC EDGAR (XBRL company facts). Full statements and ratios in the terminal.
Insider activity
5 recent insider (SEC Form 4) filings on record for MASI. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open MASI in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.